Potential effects include: Increased collagen I and III deposition Improved organization of repair tissue Better tendon and muscle remodeling after injury Support for functional recovery rather than only scar formation These effects are central to why BPC 157 is often positioned as a connective-tissue recovery peptide
this list is not exhaustive Antacids Colchicine (treatment of gout) H2 Blockers (Zantac, Tagamet, Pepcid) Metformin Diabetes drug (Glucophage) PPIs Proton pump inhibitors (Omeprazole, Nexium, Prevacid, Protonix) Nitrous oxide anaesthesia Nitrous oxide recreational abuse (Laughing gas / Whippets / Hippy crack) Mycifradin sulphate (Neomycin) antibiotic Para aminosalicylates antibiotic Phenytoin (Dilantin) anti-epileptic Potassium chloride (K-Dur) Cholestyramine (Questran) Chemotherapy and radiation treatment Increased demands Chronic Hemoltic anaemia Hyperthroidism Multiple myeloma Myelopproliferative disorders Neoplasms Pregnancy Some patients may never find out the cause of their condition, this does not mean that they should be denied B12 injections which are, safe, inexpensive and the most efficient treatment for their deficiency
But with the right trials, safety profiling, and delivery innovation, it just might be
BPC-157 interacts with the nitric oxide (NO) system in a context-dependent manner, counteracting both NO-synthase inhibition and NO excess
